$DVAX
DYNAVAX TECHNOLOGIES CORP

2016 Q1 Form 10-Q Financial Statement

#000156459016018641 Filed on May 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2015 Q1
Revenue $942.0K $685.0K $627.0K
YoY Change 50.24% -69.92% -82.08%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.430M $6.230M $4.340M
YoY Change 71.2% 23.37% 2.6%
% of Gross Profit
Research & Development $20.07M $20.93M $22.22M
YoY Change -9.69% 6.57% 67.94%
% of Gross Profit
Depreciation & Amortization $400.0K $410.0K $340.0K
YoY Change 17.65% 7.89% 0.0%
% of Gross Profit
Operating Expenses $28.24M $27.16M $27.08M
YoY Change 4.27% 10.0% 104.66%
Operating Profit -$27.29M -$26.45M
YoY Change 3.18% 89.39%
Interest Expense $230.0K $130.0K $247.0K
YoY Change -6.88% -1400.0% 252.86%
% of Operating Profit
Other Income/Expense, Net $46.00K -$40.00K $455.0K
YoY Change -89.89% -130.77% 633.87%
Pretax Income -$27.02M -$26.86M -$26.22M
YoY Change 3.05% 20.5% 89.45%
Income Tax
% Of Pretax Income
Net Earnings -$27.02M -$26.86M -$26.22M
YoY Change 3.07% 20.53% 89.43%
Net Earnings / Revenue -2868.68% -3921.46% -4181.34%
Basic Earnings Per Share
Diluted Earnings Per Share -$702.4K -$510.1K -$968.6K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q4 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $166.8M $196.1M $97.60M
YoY Change 70.9% 59.9% -45.08%
Cash & Equivalents $38.86M $44.81M $14.71M
Short-Term Investments $128.0M $151.3M $82.90M
Other Short-Term Assets $2.700M $2.400M $3.500M
YoY Change -22.86% -41.46% 52.17%
Inventory
Prepaid Expenses
Receivables $1.200M $1.400M $900.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $170.7M $199.9M $102.0M
YoY Change 67.35% 56.9% -43.86%
LONG-TERM ASSETS
Property, Plant & Equipment $15.90M $13.80M $7.500M
YoY Change 112.0% 74.73% -12.79%
Goodwill $2.043M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $900.0K $231.0K $600.0K
YoY Change 50.0% -67.0% -14.29%
Total Long-Term Assets $18.90M $16.69M $10.20M
YoY Change 85.29% 53.61% -14.29%
TOTAL ASSETS
Total Short-Term Assets $170.7M $199.9M $102.0M
Total Long-Term Assets $18.90M $16.69M $10.20M
Total Assets $189.6M $216.6M $112.2M
YoY Change 68.98% 56.64% -42.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.500M $3.433M $3.300M
YoY Change 6.06% 186.08% 73.68%
Accrued Expenses $19.30M $15.34M $10.90M
YoY Change 77.06% 142.79% 65.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $600.0K
YoY Change
Total Short-Term Liabilities $24.50M $28.80M $20.50M
YoY Change 19.51% 42.02% 28.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $8.900M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $700.0K $800.0K $7.700M
YoY Change -90.91% -25.23% 102.63%
Total Long-Term Liabilities $700.0K $800.0K $16.60M
YoY Change -95.78% -92.47% 336.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.50M $28.80M $20.50M
Total Long-Term Liabilities $700.0K $800.0K $16.60M
Total Liabilities $25.20M $29.60M $37.10M
YoY Change -32.08% -21.71% 88.32%
SHAREHOLDERS EQUITY
Retained Earnings -$726.8M -$699.7M
YoY Change
Common Stock $893.3M $889.7M
YoY Change 28.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $164.4M $187.1M $75.10M
YoY Change
Total Liabilities & Shareholders Equity $189.6M $216.6M $112.2M
YoY Change 69.02% 56.64% -42.04%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2015 Q1
OPERATING ACTIVITIES
Net Income -$27.02M -$26.86M -$26.22M
YoY Change 3.07% 20.53% 89.43%
Depreciation, Depletion And Amortization $400.0K $410.0K $340.0K
YoY Change 17.65% 7.89% 0.0%
Cash From Operating Activities -$27.13M -$21.85M -$24.14M
YoY Change 12.39% 29.52% 115.92%
INVESTING ACTIVITIES
Capital Expenditures $2.611M -$2.720M $618.0K
YoY Change 322.49% 491.3% 55.28%
Acquisitions
YoY Change
Other Investing Activities $23.36M -$33.83M -$9.900M
YoY Change -335.96% -190.05% -165.43%
Cash From Investing Activities $20.75M -$36.56M -$10.52M
YoY Change -297.24% -198.52% -171.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 340.0K 300.0K 140.0K
YoY Change 142.86% -96.93% 100.0%
NET CHANGE
Cash From Operating Activities -27.13M -21.85M -24.14M
Cash From Investing Activities 20.75M -36.56M -10.52M
Cash From Financing Activities 340.0K 300.0K 140.0K
Net Change In Cash -6.040M -58.11M -34.52M
YoY Change -82.5% -293.7% -1053.59%
FREE CASH FLOW
Cash From Operating Activities -$27.13M -$21.85M -$24.14M
Capital Expenditures $2.611M -$2.720M $618.0K
Free Cash Flow -$29.74M -$19.13M -$24.76M
YoY Change 20.13% 16.58% 113.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26228000
CY2015Q1 us-gaap Interest Expense
InterestExpense
247000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
455000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-27023000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-26217000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.97
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38472000
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27065000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
109000
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27503000
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
402000
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
335000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8169000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4859000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
28236000
CY2016Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-75000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
27079000
CY2015Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-171000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-27294000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-26452000
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
225000
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
27000
CY2016Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
686000
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1294000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
795000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1286000
CY2015Q1 dvax Accretion Of Debt Discounts Related To Debt Financing
AccretionOfDebtDiscountsRelatedToDebtFinancing
-51000
CY2015Q1 dvax Accretion Of End Of Term Payment Related To Debt Financing
AccretionOfEndOfTermPaymentRelatedToDebtFinancing
57000
CY2016Q1 dvax Cash Settled Portion Of Stock Based Compensation Expense
CashSettledPortionOfStockBasedCompensationExpense
328000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
69500000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20067000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22220000
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
893278000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
889698000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2135000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-726750000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
187079000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
216633000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2930000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-699727000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
164431000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
189644000
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap License And Services Revenue
LicenseAndServicesRevenue
8000
CY2015Q1 us-gaap Revenue From Grants
RevenueFromGrants
148000
CY2015Q1 us-gaap Revenues
Revenues
627000
CY2016Q1 us-gaap Revenue From Grants
RevenueFromGrants
39000
CY2015Q1 us-gaap License And Services Revenue
LicenseAndServicesRevenue
8000
CY2016Q1 us-gaap Revenues
Revenues
942000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38446000
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38495502
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38446000
CY2016Q1 us-gaap Contracts Revenue
ContractsRevenue
895000
CY2015Q1 us-gaap Contracts Revenue
ContractsRevenue
471000
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
69500000
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38496000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1954000
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
84420000
CY2015Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
8750000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2611000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
618000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
20752000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-10522000
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
75000
CY2015Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18654000
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000
CY2015Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
26000
CY2016Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
261000
CY2015Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
103000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
336000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
139000
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
92000
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-276000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5954000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3244000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-230000
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
182000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
301000
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-580000
CY2016Q1 dvax Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
36000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
658000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2043000
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3816000
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2357000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-895000
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-472000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-27134000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-24139000
CY2016Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
61057000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-34798000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49511000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14713000
CY2015Q1 us-gaap Interest Paid
InterestPaid
184000
CY2016Q1 dvax Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
1154000
CY2015Q1 dvax Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
4000
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates.</p></div>
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
196113000
CY2016Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2016Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
166800000
CY2016Q1 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
CY2016Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
166726000
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
122000
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
66000
CY2016Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
166847000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
196125000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
127868000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
0
CY2016Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
127868000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
127989000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
0
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
127989000
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2016Q1 us-gaap Deferred Rent Credit
DeferredRentCredit
400000
CY2015Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
500000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1757000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2385000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1327000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
485000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
485000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1091000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
7530000
CY2016Q1 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
10500000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3610000
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5310000
CY2016Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2015Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4663000
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2204000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3244000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1954000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2891000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
229000
CY2016Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2996000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1509000
CY2015Q4 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
23.34
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
21.48
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
13.69
CY2016Q1 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
22.97
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
23.09
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
26.49
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7D
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y11M23D
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M10D
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4835000

Files In Submission

Name View Source Status
0001564590-16-018641-index-headers.html Edgar Link pending
0001564590-16-018641-index.html Edgar Link pending
0001564590-16-018641.txt Edgar Link pending
0001564590-16-018641-xbrl.zip Edgar Link pending
dvax-10q_20160331.htm Edgar Link pending
dvax-20160331.xml Edgar Link completed
dvax-20160331.xsd Edgar Link pending
dvax-20160331_cal.xml Edgar Link unprocessable
dvax-20160331_def.xml Edgar Link unprocessable
dvax-20160331_lab.xml Edgar Link unprocessable
dvax-20160331_pre.xml Edgar Link unprocessable
dvax-ex311_7.htm Edgar Link pending
dvax-ex312_9.htm Edgar Link pending
dvax-ex321_6.htm Edgar Link pending
dvax-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending